Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. (Record no. 27331203)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01892 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517162416.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201806s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1872-7913 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.ijantimicag.2017.05.017 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Paiva, J A |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180613 |
| 245 00 - TITLE STATEMENT | |
| Title | Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | International journal of antimicrobial agents |
| Date of publication, distribution, etc. | Oct 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 529-535 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Amphotericin B |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antifungal Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aspergillus |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Decision-Making |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Critical Illness |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Delayed Diagnosis |
| General subdivision | mortality |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Therapy, Combination |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Echinocandins |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fungal Proteins |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Intensive Care Units |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Invasive Pulmonary Aspergillosis |
| General subdivision | diagnosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Respiratory System |
| General subdivision | microbiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Voriconazole |
| General subdivision | therapeutic use |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mergulhão, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gomes, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taccone, F S |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Van den Abeele, A-M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bulpa, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Misset, B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meersseman, W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dimopoulos, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rello, J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vogelaers, D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Blot, S |
| 773 0# - HOST ITEM ENTRY | |
| Title | International journal of antimicrobial agents |
| Related parts | vol. 50 |
| -- | no. 4 |
| -- | p. 529-535 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ijantimicag.2017.05.017">https://doi.org/10.1016/j.ijantimicag.2017.05.017</a> |
| Public note | Available from publisher's website |
No items available.